investing-statsSEC Form 4 insider transactions

TRAX · First Tracks Biotherapeutics, Inc.

← all insiders

Pharmaceutical Preparations · Listed on Nasdaq

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades1
Distinct insiders1
Bought$0
Sold$1.76M
Net flow$-1.76M

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for TRAX
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-09-04Ware J. AnthonyDirectorM sell10,694 10,694 Common Stock0filing
2026-09-04Ware J. AnthonyDirectorM sell28,571 28,571 Common Stock0filing
2026-09-04Ware J. AnthonyDirectorS sell39,2650$44.78$1.76M15,660−71%−0.11% (now 0.04%)filing
2026-09-04Ware J. AnthonyDirectorM buy39,2650$5.74$225.4K54,9253.5×+0.11% (now 0.15%)filing
2026-08-18STONE BENJAMINOfficer (Chief Business Officer)A buy60,492 60,492 Common Stock137,651filing
2026-08-18Lizzul Paul F.Officer (Chief Medical Officer)A buy60,492 60,492 Common Stock137,651filing
2026-08-18Faga DanielDirector, Officer (President, CEO)A buy193,575 193,575 Common Stock440,485filing
2026-08-05STONE BENJAMINOfficer (Chief Business Officer)A buy60,492 60,492 Common Stock77,159filing
2026-08-05Lizzul Paul F.Officer (Chief Medical Officer)A buy60,492 60,492 Common Stock77,159filing
2026-08-05Faga DanielDirector, Officer (President, CEO)A buy193,576 193,576 Common Stock387,156filing
2026-06-17Ware J. AnthonyDirectorM sell6,030 6,030 Common Stock0filing
2026-06-17Ware J. AnthonyDirectorM buy6,030015,660+63%+0.02% (now 0.04%)filing
2026-06-17Jain RitaDirectorM sell1,300 1,300 Common Stock0filing
2026-06-17Jain RitaDirectorM sell6,030 6,030 Common Stock0filing
2026-06-17Jain RitaDirectorM buy7,330019,194+62%+0.02% (now 0.05%)filing
2026-06-17Marquet MagdaDirectorM sell6,030 6,030 Common Stock0filing
2026-06-17Marquet MagdaDirectorM buy6,030015,960+61%+0.02% (now 0.04%)filing
2026-06-17Schmid John P.DirectorM sell6,030 6,030 Common Stock0filing
2026-06-17Schmid John P.DirectorM buy6,030037,652+19%+0.02% (now 0.11%)filing
2026-06-17Orwin John ADirectorM sell6,030 6,030 Common Stock0filing
2026-06-17Orwin John ADirectorM buy6,030016,695+57%+0.02% (now 0.05%)filing
2026-06-17FENTON DENNIS MDirectorM sell6,030 6,030 Common Stock0filing
2026-06-17FENTON DENNIS MDirectorM buy6,030010,9952.2×+0.02% (now 0.03%)filing
2026-05-14STONE BENJAMINOfficer (Chief Business Officer)A buy72,300 72,300 Common Stock72,300filing
2026-05-14STONE BENJAMINOfficer (Chief Business Officer)A buy26,700 26,700 Common Stock26,700filing
2026-05-14Tamboli AjimOfficer (Chief Financial Officer)A buy13,600 13,600 Common Stock13,600filing
2026-05-14Tamboli AjimOfficer (Chief Financial Officer)A buy5,000 5,000 Common Stock5,000filing
2026-05-14Ware J. AnthonyDirectorA buy42,000 42,000 Common Stock42,000filing
2026-05-14Ware J. AnthonyDirectorA buy15,000 15,000 Common Stock15,000filing
2026-05-14Lizzul Paul F.Officer (Chief Medical Officer)A buy72,300 72,300 Common Stock72,300filing
2026-05-14Lizzul Paul F.Officer (Chief Medical Officer)A buy26,700 26,700 Common Stock26,700filing
2026-05-14Jain RitaDirectorA buy42,000 42,000 Common Stock42,000filing
2026-05-14Jain RitaDirectorA buy15,000 15,000 Common Stock15,000filing
2026-05-14Marquet MagdaDirectorA buy42,000 42,000 Common Stock42,000filing
2026-05-14Marquet MagdaDirectorA buy15,000 15,000 Common Stock15,000filing
2026-05-14Schmid John P.DirectorA buy42,000 42,000 Common Stock42,000filing
2026-05-14Schmid John P.DirectorA buy15,000 15,000 Common Stock15,000filing
2026-05-14Orwin John ADirectorA buy42,000 42,000 Common Stock42,000filing
2026-05-14Orwin John ADirectorA buy15,000 15,000 Common Stock15,000filing
2026-05-14Faga DanielDirector, Officer (President, CEO)A buy271,100 271,100 Common Stock271,100filing
2026-05-14Faga DanielDirector, Officer (President, CEO)A buy100,200 100,200 Common Stock100,200filing
2026-05-14FENTON DENNIS MDirectorA buy42,000 42,000 Common Stock42,000filing
2026-05-14FENTON DENNIS MDirectorA buy15,000 15,000 Common Stock15,000filing
2026-04-23Tamboli AjimOfficer (Chief Financial Officer)A buy41,234 41,234 Common Stock41,234filing
2026-04-23Tamboli AjimOfficer (Chief Financial Officer)A buy41,233 41,233 Common Stock41,233filing
2026-04-23Tamboli AjimOfficer (Chief Financial Officer)A buy41,233 41,233 Common Stock41,233filing
2026-04-23Tamboli AjimOfficer (Chief Financial Officer)A buy45,700 45,700 Common Stock45,700filing
2026-04-22Ware J. AnthonyDirectorA buy4,000 4,000 Common Stock4,000filing
2026-04-22Ware J. AnthonyDirectorA buy6,030 6,030 Common Stock6,030filing
2026-04-22Ware J. AnthonyDirectorA buy5,500 5,500 Common Stock5,500filing
2026-04-22Ware J. AnthonyDirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22Ware J. AnthonyDirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22Ware J. AnthonyDirectorA buy10,600 10,600 Common Stock10,600filing
2026-04-22Ware J. AnthonyDirectorA buy9,200 9,200 Common Stock9,200filing
2026-04-22Ware J. AnthonyDirectorA buy11,000 11,000 Common Stock11,000filing
2026-04-22Ware J. AnthonyDirectorA buy11,000 11,000 Common Stock11,000filing
2026-04-22Ware J. AnthonyDirectorA buy6,000 6,000 Common Stock6,000filing
2026-04-22Ware J. AnthonyDirectorA buy6,000 6,000 Common Stock6,000filing
2026-04-22Ware J. AnthonyDirectorA buy10,694 10,694 Common Stock10,694filing
2026-04-22Ware J. AnthonyDirectorA buy28,571 28,571 Common Stock28,571filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy21,400 21,400 Common Stock21,400filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy25,575 25,575 Common Stock25,575filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy21,110 21,110 Common Stock21,110filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy6,145 6,145 Common Stock6,145filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy29,000 29,000 Common Stock29,000filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy97,200 97,200 Common Stock97,200filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy115,540 115,540 Common Stock115,540filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy67,070 67,070 Common Stock67,070filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy70,000 70,000 Common Stock70,000filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy45,000 45,000 Common Stock45,000filing
2026-04-22Lizzul Paul F.Officer (Chief Medical Officer)A buy83,500 83,500 Common Stock83,500filing
2026-04-22Jain RitaDirectorA buy4,000 4,000 Common Stock4,000filing
2026-04-22Jain RitaDirectorA buy6,030 6,030 Common Stock6,030filing
2026-04-22Jain RitaDirectorA buy1,300 1,300 Common Stock1,300filing
2026-04-22Jain RitaDirectorA buy5,500 5,500 Common Stock5,500filing
2026-04-22Jain RitaDirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22Jain RitaDirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22Jain RitaDirectorA buy8,015 8,015 Common Stock8,015filing
2026-04-22Jain RitaDirectorA buy10,600 10,600 Common Stock10,600filing
2026-04-22Marquet MagdaDirectorA buy4,000 4,000 Common Stock4,000filing
2026-04-22Marquet MagdaDirectorA buy6,030 6,030 Common Stock6,030filing
2026-04-22Marquet MagdaDirectorA buy5,500 5,500 Common Stock5,500filing
2026-04-22Marquet MagdaDirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22Marquet MagdaDirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22Marquet MagdaDirectorA buy10,600 10,600 Common Stock10,600filing
2026-04-22Marquet MagdaDirectorA buy9,200 9,200 Common Stock9,200filing
2026-04-22Marquet MagdaDirectorA buy11,000 11,000 Common Stock11,000filing
2026-04-22Marquet MagdaDirectorA buy784 784 Common Stock784filing
2026-04-22Schmid John P.DirectorA buy4,000 4,000 Common Stock4,000filing
2026-04-22Schmid John P.DirectorA buy6,030 6,030 Common Stock6,030filing
2026-04-22Schmid John P.DirectorA buy5,500 5,500 Common Stock5,500filing
2026-04-22Schmid John P.DirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22Schmid John P.DirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22Schmid John P.DirectorA buy10,600 10,600 Common Stock10,600filing
2026-04-22Schmid John P.DirectorA buy9,200 9,200 Common Stock9,200filing
2026-04-22Schmid John P.DirectorA buy11,000 11,000 Common Stock11,000filing
2026-04-22Schmid John P.DirectorA buy11,000 11,000 Common Stock11,000filing
2026-04-22Schmid John P.DirectorA buy6,000 6,000 Common Stock6,000filing
2026-04-22Schmid John P.DirectorA buy6,000 6,000 Common Stock6,000filing
2026-04-22Schmid John P.DirectorA buy15,000 15,000 Common Stock15,000filing
2026-04-22Orwin John ADirectorA buy6,000 6,000 Common Stock6,000filing
2026-04-22Orwin John ADirectorA buy6,030 6,030 Common Stock6,030filing
2026-04-22Orwin John ADirectorA buy1,300 1,300 Common Stock1,300filing
2026-04-22Orwin John ADirectorA buy8,250 8,250 Common Stock8,250filing
2026-04-22Orwin John ADirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22Orwin John ADirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22Orwin John ADirectorA buy10,600 10,600 Common Stock10,600filing
2026-04-22Orwin John ADirectorA buy3,311 3,311 Common Stock3,311filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy98,600 98,600 Common Stock98,600filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy80,512 80,512 Common Stock80,512filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy69,355 69,355 Common Stock69,355filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy17,850 17,850 Common Stock17,850filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy133,400 133,400 Common Stock133,400filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy305,500 305,500 Common Stock305,500filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy379,620 379,620 Common Stock379,620filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy194,900 194,900 Common Stock194,900filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy9,200 9,200 Common Stock9,200filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy2,321 2,321 Common Stock2,321filing
2026-04-22Faga DanielDirector, Officer (President, CEO)A buy11,000 11,000 Common Stock11,000filing
2026-04-22FENTON DENNIS MDirectorA buy4,000 4,000 Common Stock4,000filing
2026-04-22FENTON DENNIS MDirectorA buy6,030 6,030 Common Stock6,030filing
2026-04-22FENTON DENNIS MDirectorA buy5,500 5,500 Common Stock5,500filing
2026-04-22FENTON DENNIS MDirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22FENTON DENNIS MDirectorA buy16,510 16,510 Common Stock16,510filing
2026-04-22FENTON DENNIS MDirectorA buy10,600 10,600 Common Stock10,600filing
2026-04-22FENTON DENNIS MDirectorA buy9,200 9,200 Common Stock9,200filing
2026-04-22FENTON DENNIS MDirectorA buy11,000 11,000 Common Stock11,000filing
2026-04-22FENTON DENNIS MDirectorA buy11,000 11,000 Common Stock11,000filing
2026-04-22FENTON DENNIS MDirectorA buy6,000 6,000 Common Stock6,000filing
2026-04-22FENTON DENNIS MDirectorA buy5,507 5,507 Common Stock5,507filing
2026-04-22FENTON DENNIS MDirectorA buy6,000 6,000 Common Stock6,000filing
2026-04-22EcoR1 Capital, LLC10% ownerS buy4,705,5750$13.81$65.00M3,174,519new+13% (now 8.9%)filing
2026-04-22ANAPTYSBIO, INC10% ownerJ sell10000−100%−<0.01% (now 0%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.